Five Prime Therapeutics
Utility Patents
Last updated:
List of all Five Prime Therapeutics patents 17 in total
| Status | Patent |
|---|---|
Grant | Utility: FGFR2 inhibitors alone or in combination with immune stimulating agents in cancer treatment Filling date: 26 Sep 2025 Issue date: 20 Sep 2022 |
Grant | Utility: Combination anti-CSF1R and anti-PD-1 antibody combination therapy for pancreatic cancer Filling date: 26 Sep 2025 Issue date: 23 Aug 2022 |
Grant | Utility: Antibodies binding to ILT4 Filling date: 26 Sep 2025 Issue date: 2 Aug 2022 |
Grant | Utility: B7-H4 antibodies and methods of use thereof Filling date: 26 Sep 2025 Issue date: 19 Apr 2022 |
Grant | Utility: Afucosylated anti-FGFR2IIIB antibodies Filling date: 26 Sep 2025 Issue date: 1 Feb 2022 |
Grant | Utility: Antibodies that bind colony stimulating factor 1 receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 30 Nov 2021 |
Grant | Utility: Anti-ROR1 antibodies Filling date: 26 Sep 2025 Issue date: 26 Oct 2021 |
Grant | Utility: CD80 extracellular domain polypeptides and their use in cancer treatment Filling date: 26 Sep 2025 Issue date: 24 Aug 2021 |
Grant | Utility: Method of treating gastric cancer with anti-FGFR2-IIIb antibodies and modified FOLFOX6 chemotherapy Filling date: 26 Sep 2025 Issue date: 17 Aug 2021 |
Grant | Utility: Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 20 Apr 2021 |
Grant | Utility: Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 13 Apr 2021 |
Grant | Utility: Methods of treating conditions with antibodies that bind colony stimulating factor 1 receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 3 Nov 2020 |
Grant | Utility: NOPE for treatment of pathological muscle loss and weakness Filling date: 26 Sep 2025 Issue date: 13 Oct 2020 |
Grant | Utility: Method of treating PVNS with anti-CSF1R antibodies Filling date: 26 Sep 2025 Issue date: 4 Aug 2020 |
Grant | Utility: Anti-CSF1R antibody and anti PD-1 antibody combination therapy for cancer Filling date: 26 Sep 2025 Issue date: 14 Apr 2020 |
Grant | Utility: Antibodies that bind colony stimulating factor 1 receptor (CSF1R) Filling date: 26 Sep 2025 Issue date: 18 Feb 2020 |
Grant | Utility: Methods of treating lung cancer Filling date: 26 Sep 2025 Issue date: 21 Jan 2020 |
Showing 1 to 17 of 17 patents.